Ticker
VIR
Analysis
Vir Biotechnology, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to VIR.
Vir Biotechnology, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to VIR.
VIR
Stock
$1.45B
Health Technology
Biotechnology
USD
Vir Biotechnology, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of
SAN FRANCISCO, May 18, 2026--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will present data from the Phase 2 SOLSTICE trial evaluating the combination of to...
Key market opportunities for Sotrovimab (Xevudy) include increased prevalence of COVID-19, necessitating early-stage treatment and high-risk patient protection; rising healthcar...
SAN FRANCISCO, May 06, 2026--Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported financial results for the first quarter ended March 31, 2026.
SAN FRANCISCO, May 05, 2026--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fi...
Review valuation context for Vir Biotechnology, Inc..
Review future growth context for Vir Biotechnology, Inc..
Review past performance context for Vir Biotechnology, Inc..
Review financial health context for Vir Biotechnology, Inc..
Review dividend context for Vir Biotechnology, Inc..
Review management context for Vir Biotechnology, Inc..
Review ownership context for Vir Biotechnology, Inc..
Review other information context for Vir Biotechnology, Inc..
Review community context for Vir Biotechnology, Inc..